Advertisement
Singapore markets closed

  • Straits Times Index

    3,323.20
    -6.89 (-0.21%)
     

  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     

  • Dow

    38,852.86
    -216.74 (-0.55%)
     

  • Nasdaq

    17,019.88
    +99.08 (+0.59%)
     

  • Bitcoin USD

    67,897.25
    -681.87 (-0.99%)
     

  • CMC Crypto 200

    1,464.12
    -20.57 (-1.39%)
     

  • FTSE 100

    8,228.82
    -25.36 (-0.31%)
     

  • Gold

    2,345.50
    -11.00 (-0.47%)
     

  • Crude Oil

    80.49
    +0.66 (+0.83%)
     

  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     

  • Nikkei

    38,556.87
    -298.50 (-0.77%)
     

  • Hang Seng

    18,477.01
    -344.15 (-1.83%)
     

  • FTSE Bursa Malaysia

    1,605.35
    -10.47 (-0.65%)
     

  • Jakarta Composite Index

    7,140.23
    -113.40 (-1.56%)
     

  • PSE Index

    6,411.41
    -89.93 (-1.38%)
     

Investors in TalkMed Group (SGX:5G3) have unfortunately lost 5.0% over the last five years

editorial-team@simplywallst.com (Simply Wall St)
·3-min read

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may be questioning their investment in TalkMed Group Limited (SGX:5G3), since the last five years saw the share price fall 25%.

Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.

See our latest analysis for TalkMed Group

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

ADVERTISEMENT

During the unfortunate half decade during which the share price slipped, TalkMed Group actually saw its earnings per share (EPS) improve by 2.0% per year. So it doesn't seem like EPS is a great guide to understanding how the market is valuing the stock. Or possibly, the market was previously very optimistic, so the stock has disappointed, despite improving EPS.

By glancing at these numbers, we'd posit that the the market had expectations of much higher growth, five years ago. Looking to other metrics might better explain the share price change.

The steady dividend doesn't really explain why the share price is down. While it's not completely obvious why the share price is down, a closer look at the company's history might help explain it.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

earnings-and-revenue-growth
earnings-and-revenue-growth

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of TalkMed Group, it has a TSR of -5.0% for the last 5 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

A Different Perspective

TalkMed Group shareholders gained a total return of 2.9% during the year. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 1.0% endured over half a decade. It could well be that the business is stabilizing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 3 warning signs for TalkMed Group you should be aware of, and 1 of them makes us a bit uncomfortable.

But note: TalkMed Group may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.